NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts
NCT01529827 2019-09-24Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesRoswell Park Cancer InstitutePhase 2 Completed94 enrolled 11 charts
NCT00589563 2014-09-10Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerCity of Hope Medical CenterPhase 2 Completed32 enrolled 24 charts
NCT00008307 2014-01-06Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersNational Cancer Institute (NCI)Phase 2 Unknown52 enrolled
NCT00827099 2012-03-23Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerNorthside Hospital, Inc.Phase 2 Terminated5 enrolled 5 charts